S E Combs1, J Debus. 1. RadioOnkologie und Strahlentherapie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland, Stephanie.Combs@med.uni-heidelberg.de.
Abstract
BACKGROUND: Recent developments and innovations in modern radiation oncology enable radiation oncologists to deliver a biologically, physically and technically stratified individualized treatment. In urological oncology, radiotherapy can be offered as a valid treatment alternative for a number of tumors, such as prostate cancer or urothelial cancer/bladder cancer. METHODS: By improving the precision of radiotherapy, significant improvement in tumor control can be achieved, coupled with a reduction of the risk of treatment-related side effects. Techniques such as high precision radiotherapy and combinations of radiation and modern imaging, such as image-guided radiotherapy (IGRT) and adaptive radiotherapy (ART), make daily individually tailored treatment possible. CONCLUSIONS: In the future the biological characteristics of tumors and of normal tissue as well as molecular markers can be used for treatment stratification.
BACKGROUND: Recent developments and innovations in modern radiation oncology enable radiation oncologists to deliver a biologically, physically and technically stratified individualized treatment. In urological oncology, radiotherapy can be offered as a valid treatment alternative for a number of tumors, such as prostate cancer or urothelial cancer/bladder cancer. METHODS: By improving the precision of radiotherapy, significant improvement in tumor control can be achieved, coupled with a reduction of the risk of treatment-related side effects. Techniques such as high precision radiotherapy and combinations of radiation and modern imaging, such as image-guided radiotherapy (IGRT) and adaptive radiotherapy (ART), make daily individually tailored treatment possible. CONCLUSIONS: In the future the biological characteristics of tumors and of normal tissue as well as molecular markers can be used for treatment stratification.
Authors: Ala Yaromina; Theresa Kroeber; Andreas Meinzer; Simon Boeke; Howard Thames; Michael Baumann; Daniel Zips Journal: Int J Radiat Oncol Biol Phys Date: 2011-04-12 Impact factor: 7.038
Authors: Susan L Tucker; Ming Zhang; Lei Dong; Radhe Mohan; Deborah Kuban; Howard D Thames Journal: Int J Radiat Oncol Biol Phys Date: 2006-03-15 Impact factor: 7.038
Authors: Danny Y Song; Klaus K Herfarth; Matthias Uhl; Michael J Eble; Michael Pinkawa; Baukelien van Triest; Robin Kalisvaart; Damien C Weber; Raymond Miralbell; Theodore L Deweese; Eric C Ford Journal: Int J Radiat Oncol Biol Phys Date: 2013-02-13 Impact factor: 7.038
Authors: Amish P Shah; Patrick A Kupelian; Twyla R Willoughby; Katja M Langen; Sanford L Meeks Journal: Radiother Oncol Date: 2011-03-30 Impact factor: 6.280
Authors: Daniel Zips; Simon Böke; Theresa Kroeber; Andreas Meinzer; Kerstin Brüchner; Howard D Thames; Michael Baumann; Ala Yaromina Journal: Strahlenther Onkol Date: 2011-04-26 Impact factor: 3.621
Authors: M J Zelefsky; Z Fuks; L Happersett; H J Lee; C C Ling; C M Burman; M Hunt; T Wolfe; E S Venkatraman; A Jackson; M Skwarchuk; S A Leibel Journal: Radiother Oncol Date: 2000-06 Impact factor: 6.280
Authors: Eugene Huang; Lei Dong; Anurag Chandra; Deborah A Kuban; Isaac I Rosen; Anissa Evans; Alan Pollack Journal: Int J Radiat Oncol Biol Phys Date: 2002-06-01 Impact factor: 7.038
Authors: Anthony L Zietman; Kyounghwa Bae; Jerry D Slater; William U Shipley; Jason A Efstathiou; John J Coen; David A Bush; Margie Lunt; Daphna Y Spiegel; Rafi Skowronski; B Rodney Jabola; Carl J Rossi Journal: J Clin Oncol Date: 2010-02-01 Impact factor: 44.544